Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalitiesYang Liu(Dana-Farber Cancer Institute), Franziska Michor(Harvard University)Cell GenomicsNovember 21, 202310.1016/j.xgen.2023.100444Cited by 29SaveCiteExport RISWatch citationsRelated PapersAberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity|PLoS Genetics|2013|123